SCA
PDLI
SMH Capital Advisors’s PDL BioPharma, Inc. PDLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-162,336
| Closed | -$511K | – | 51 |
|
|
2020
Q3 | $511K | Buy |
162,336
+84,629
| +109% | +$266K | 1.19% | 8 |
|
|
2020
Q2 | $226K | Buy |
77,707
+919
| +1% | +$2.67K | 0.45% | 23 |
|
|
2020
Q1 | $217K | Sell |
76,788
-3,275
| -4% | -$9.26K | 0.46% | 19 |
|
|
2019
Q4 | $260K | Sell |
80,063
-1,650
| -2% | -$5.36K | 0.52% | 22 |
|
|
2019
Q3 | $176K | Sell |
81,713
-3,655
| -4% | -$7.87K | 0.39% | 30 |
|
|
2019
Q2 | $268K | Hold |
85,368
| – | – | 0.65% | 23 |
|
|
2019
Q1 | $318K | Buy |
85,368
+2,009
| +2% | +$7.48K | 0.62% | 19 |
|
|
2018
Q4 | $242K | Sell |
83,359
-10,349
| -11% | -$30K | 0.49% | 20 |
|
|
2018
Q3 | $246K | Buy |
93,708
+10,339
| +12% | +$27.1K | 0.42% | 25 |
|
|
2018
Q2 | $195K | Buy |
83,369
+2,647
| +3% | +$6.19K | 0.32% | 27 |
|
|
2018
Q1 | $237K | Buy |
80,722
+785
| +1% | +$2.31K | 0.37% | 25 |
|
|
2017
Q4 | $219K | Buy |
+79,937
| New | +$219K | 0.37% | 26 |
|